StockMacro
Menu

MaxCyte

$1.37 +37% in 6 monthsMarket cap $141.5M

MXCT on XNAS, Health Care, MaxCyte, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue flat at $34.4M over 12 months while the company burned $21.4M in cash.

  • BadNet loss $28M over 12 months and cash at $101.3M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Industry
Services-commercial physical & biological research (Health Care)
Employees
91
Website
maxcyte.com
Listed
Nasdaq, US
Last results
10 Nov 2026
Next results
expected around 11 Jan 2027 (an estimate: a year ago it reported on 12 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $10.2M, net loss $4.8M.
Quarter to 31 Dec 2021: revenue $10.2M, net income -$4.9MQuarter to 31 Dec 2021: revenue $10.2M, net income -$4.9MQuarter to 31 Mar 2022: revenue $11.6M, net income -$4.1MQuarter to 31 Mar 2022: revenue $11.6M, net income -$4.1MQuarter to 30 Jun 2022: revenue $9.6M, net income -$8.3MQuarter to 30 Jun 2022: revenue $9.6M, net income -$8.3MQuarter to 30 Sep 2022: revenue $10.6M, net income -$6.4MQuarter to 30 Sep 2022: revenue $10.6M, net income -$6.4MQuarter to 31 Dec 2022: revenue $12.4M, net income -$4.8MQuarter to 31 Dec 2022: revenue $12.4M, net income -$4.8MQuarter to 31 Mar 2023: revenue $8.6M, net income -$10.9MQuarter to 31 Mar 2023: revenue $8.6M, net income -$10.9MQuarter to 30 Jun 2023: revenue $9.0M, net income -$10.5MQuarter to 30 Jun 2023: revenue $9.0M, net income -$10.5MQuarter to 30 Sep 2023: revenue $8.0M, net income -$11.3MQuarter to 30 Sep 2023: revenue $8.0M, net income -$11.3MQuarter to 31 Dec 2023: revenue $15.7M, net income -$5.3MQuarter to 31 Dec 2023: revenue $15.7M, net income -$5.3MQuarter to 31 Mar 2024: revenue $11.3M, net income -$9.5MQuarter to 31 Mar 2024: revenue $11.3M, net income -$9.5MQuarter to 30 Jun 2024: revenue $10.4M, net income -$9.4MQuarter to 30 Jun 2024: revenue $10.4M, net income -$9.4MQuarter to 30 Sep 2024: revenue $8.2M, net income -$11.6MQuarter to 30 Sep 2024: revenue $8.2M, net income -$11.6MQuarter to 31 Dec 2024: revenue $8.7M, net income -$10.6MQuarter to 31 Dec 2024: revenue $8.7M, net income -$10.6MQuarter to 31 Mar 2025: revenue $10.4M, net income -$10.3MQuarter to 31 Mar 2025: revenue $10.4M, net income -$10.3MQuarter to 30 Jun 2025: revenue $8.5M, net income -$12.4MQuarter to 30 Jun 2025: revenue $8.5M, net income -$12.4MQuarter to 30 Sep 2025: revenue $6.8M, net income -$12.4MQuarter to 30 Sep 2025: revenue $6.8M, net income -$12.4MQuarter to 31 Dec 2025: revenue $7.3M, net income -$9.6MQuarter to 31 Dec 2025: revenue $7.3M, net income -$9.6MQuarter to 31 Mar 2026: revenue $9.7M, net income -$4.8MQuarter to 31 Mar 2026: revenue $9.7M, net income -$4.8MQuarter to 30 Jun 2026: revenue $7.3M, net income -$8.9MQuarter to 30 Jun 2026: revenue $7.3M, net income -$8.9MQuarter to 30 Sep 2026: revenue $10.2M, net income -$4.8MQuarter to 30 Sep 2026: revenue $10.2M, net income -$4.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $15.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$10.2M-$4.8M
30 Jun 2026$7.3M-$8.9M
31 Mar 2026$9.7M-$4.8M
31 Dec 2025$7.3M-$9.6M
30 Sep 2025$6.8M-$12.4M
30 Jun 2025$8.5M-$12.4M
31 Mar 2025$10.4M-$10.3M
31 Dec 2024$8.7M-$10.6M
30 Sep 2024$8.2M-$11.6M
30 Jun 2024$10.4M-$9.4M
31 Mar 2024$11.3M-$9.5M
31 Dec 2023$15.7M-$5.3M
30 Sep 2023$8.0M-$11.3M
30 Jun 2023$9.0M-$10.5M
31 Mar 2023$8.6M-$10.9M
31 Dec 2022$12.4M-$4.8M
30 Sep 2022$10.6M-$6.4M
30 Jun 2022$9.6M-$8.3M
31 Mar 2022$11.6M-$4.1M
31 Dec 2021$10.2M-$4.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $34.4M $34.4M
Revenue growthRevenue of the last 12 months compared with the 12 months before. -0.1% +3.4%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$28.0M -$45.6M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.26 -$0.44
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 81.0% 80.0% 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -98.0% -156% 4.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -81.4% -133% 1.0%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -16.9% -16.5%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$21.4M -$41.2M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $101.3M $105.7M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$101.3M (net cash) -$105.7M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.00
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.46
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 57.9
P/SPrice to sales: market cap divided by revenue of the last 12 months. 4.1 4.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.2 4.4
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.94 4.4

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
MaxCyteMXCT (this company) $141.5Mloss4.1-0.1%-81.4%
IB AcquisitionIBAC $53.1Mloss–––
NRC HealthNRC $533.9M82.93.7+3.4%4.5%
OmniAbOABI $679.7Mloss16.9+91%-108%
OneMedNetONMD $29.1Mloss12.7+365%-453%
AbsciABSI $1.3Bloss872-47%–

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$121K

bought $121K, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-1.7%

118 13F filers vs 120

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

58%

60.0M shares held by 13F filers (30 Sep 2026) of 103.3M outstanding (6 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

1.5%

1.6M shares sold short (30 Oct 2026) of 103.3M outstanding (6 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.3

1.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-14%

1.8M shares sold short in the report before, 1.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

11%

11% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 29%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$181K

the 12 months before: $50K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

8

8 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

8 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $1.37 on 20 Nov 2026, -16% over 12 months (12-month range $0.68 to $1.76)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $112K in the last 12 months (the 12 months before: $373K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months, -67% on the 12 months before.
Revenue per quarter. Revenue $10.2M in the latest quarter, +49% on a year earlier.
Capital spending per quarter. Capital spending $59K in the latest quarter, -80% on a year earlier.
Institutional holders (13F filers). 118 13F filers reported holding it in the latest 13F quarter, +7.3% on a year earlier.
Federal obligations. Federal obligations: $252K published in the last 12 months, +141% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Jun 20268-K and other filingsDelisting notice or listing transfer
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 33 vs usual 14.50 (2026-03-31); 3.3x the same period a year earlier
12 May 2026Sharp changeShort interest spike: short interest spike, 5.2M vs usual 3.5M (2026-04-30); 1.5x the same period a year earlier
28 Apr 2026Sharp changeShort interest spike: short interest spike, 5.4M vs usual 3.5M (2026-04-15); 1.6x the same period a year earlier
14 Apr 2026Sharp changeShort interest spike: short interest spike, 5.6M vs usual 3.5M (2026-03-31); 1.7x the same period a year earlier
31 Mar 2026Sharp changeShort interest spike: short interest spike, 5.5M vs usual 3.5M (2026-03-13); 1.8x the same period a year earlier
27 Mar 20268-K and other filingsDirector or officer change
27 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Mar 20268-K and other filingsDelisting notice or listing transfer
17 Mar 2026Sharp changeShort interest spike: short interest spike, 5.8M vs usual 3.4M (2026-02-27); 2.1x the same period a year earlier
3 Mar 2026Sharp changeShort interest spike: short interest spike, 5.1M vs usual 3.4M (2026-02-13); 1.8x the same period a year earlier
22 Sep 20258-K and other filingsRestructuring costs announced
14 Aug 2025Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 5 filing(s) in 30 days, value_usd total 480K)
11 Aug 20258-K and other filingsDirector or officer change
18 Jun 20258-K and other filingsDirector or officer change
18 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Dec 20248-K and other filingsDirector or officer change
9 Dec 20248-K and other filingsRestructuring costs announced
15 Oct 20248-K and other filingsDirector or officer change
15 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Jun 20248-K and other filingsDirector or officer change
12 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Jan 20248-K and other filingsDirector or officer change
16 Jan 2024Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.2M (2023-12-29); 2.1x the same period a year earlier
2 Jan 2024Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.1M (2023-12-15); 2.3x the same period a year earlier
11 Dec 20238-K and other filingsDirector or officer change
11 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Nov 2023Sharp changeShort interest spike: short interest spike, 3.0M vs usual 2.0M (2023-11-15); 1.5x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 3.3M vs usual 2.0M (2023-10-31); 1.2x the same period a year earlier
23 Jun 20238-K and other filingsDirector or officer change
28 Mar 20238-K and other filingsDirector or officer change
28 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Dec 20228-K and other filingsDirector or officer change
1 Dec 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Aug 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 6.8M vs usual 963K (2022-06-30); 7.1x the same period a year earlier
30 Jun 20228-K and other filingsDirector or officer change
10 May 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 6.0M vs usual 813K (2022-03-31); 19.4x the same period a year earlier
12 Apr 20228-K and other filingsDirector or officer change
12 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Nov 2021: $222K published
Month from 1 Jul 2022: -$13.9M published
Month from 1 Oct 2022: -$4.7M published
Month from 1 Nov 2022: -$202K published
Month from 1 Dec 2022: -$169K published
Month from 1 Jan 2023: -$300K published
Month from 1 Feb 2023: -$338K published
Month from 1 Mar 2023: $346K published
Month from 1 Apr 2023: -$593K published
Month from 1 May 2023: -$81K published
Month from 1 Jun 2023: -$287K published
Month from 1 Jul 2023: -$175K published
Month from 1 Aug 2023: -$18K published
Month from 1 Nov 2023: -$60K published
Month from 1 Dec 2023: -$790K published
Month from 1 Jan 2024: -$26K published
Month from 1 Feb 2024: -$23K published
Month from 1 Mar 2024: -$22K published
Month from 1 Jun 2024: $353K published
Month from 1 Jul 2024: -$188K published
Month from 1 Aug 2024: -$161K published
Month from 1 Sep 2024: -$192K published
Month from 1 Oct 2024: -$201K published
Month from 1 Nov 2024: -$177K published
Month from 1 Dec 2024: -$23K published
Month from 1 Jan 2025: -$34K published
Month from 1 Mar 2025: -$27K published
Month from 1 Aug 2025: $458K published
Month from 1 Mar 2026: -$8K published
Month from 1 Nov 2026: $121K published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 1 published
Quarter from 1 Oct 2022: 2 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Apr 2025: 2 published
Quarter from 1 Jul 2025: 1 published
Quarter from 1 Jul 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2020: $8.5M; public on 23 Mar 2022
Quarter ended 31 Mar 2021: $6.5M; public on 10 May 2022
Quarter ended 31 Dec 2021: $10.2M, +19% on a year earlier; public on 23 Mar 2022
Quarter ended 31 Mar 2022: $11.6M, +78% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $9.6M, +35% on a year earlier; public on 11 Aug 2022
Quarter ended 30 Sep 2022: $10.6M, +5.0% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $12.4M, +22% on a year earlier; public on 16 Mar 2023
Quarter ended 31 Mar 2023: $8.6M, -26% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $9.0M, -5.9% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $8.0M, -25% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $15.7M, +26% on a year earlier; public on 13 Mar 2024
Quarter ended 31 Mar 2024: $11.3M, +32% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $10.4M, +15% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $8.2M, +2.0% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $8.7M, -45% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $10.4M, -8.4% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $8.5M, -18% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $6.8M, -16% on a year earlier; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $7.3M, -16% on a year earlier; public on 26 Mar 2026
Quarter ended 31 Mar 2026: $9.7M, -7.1% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $7.3M, -15% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $10.2M, +49% on a year earlier; public on 11 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2020: $359K; public on 23 Mar 2022
Quarter ended 31 Mar 2021: $308K; public on 10 May 2022
Quarter ended 31 Dec 2021: $1.1M, +213% on a year earlier; public on 23 Mar 2022
Quarter ended 31 Mar 2022: $6.0M, +1845% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $6.8M, +607% on a year earlier; public on 11 Aug 2022
Quarter ended 30 Sep 2022: $3.5M, +141% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $2.2M, +96% on a year earlier; public on 16 Mar 2023
Quarter ended 31 Mar 2023: $1.6M, -74% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $507K, -93% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $720K, -79% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $915K, -58% on a year earlier; public on 13 Mar 2024
Quarter ended 31 Mar 2024: $804K, -48% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $294K, -42% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $406K, -44% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $147K, -84% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $653K, -19% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $584K, +99% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $300K, -26% on a year earlier; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $231K, +57% on a year earlier; public on 26 Mar 2026
Quarter ended 31 Mar 2026: $72K, -89% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $62K, -89% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $59K, -80% on a year earlier; public on 11 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 93; public on 14 Feb 2022
31 Mar 2022 report: 95; public on 16 May 2022
30 Jun 2022 report: 99; public on 15 Aug 2022
30 Sep 2022 report: 96; public on 14 Nov 2022
31 Dec 2022 report: 98; public on 14 Feb 2023
31 Mar 2023 report: 110; public on 15 May 2023
30 Jun 2023 report: 109; public on 14 Aug 2023
30 Sep 2023 report: 115; public on 14 Nov 2023
31 Dec 2023 report: 114; public on 14 Feb 2024
31 Mar 2024 report: 120; public on 15 May 2024
30 Jun 2024 report: 110; public on 14 Aug 2024
30 Sep 2024 report: 117; public on 14 Nov 2024
31 Dec 2024 report: 117; public on 14 Feb 2025
31 Mar 2025 report: 111; public on 15 May 2025
30 Jun 2025 report: 114; public on 14 Aug 2025
30 Sep 2025 report: 110; public on 14 Nov 2025
31 Dec 2025 report: 107; public on 17 Feb 2026
31 Mar 2026 report: 128; public on 15 May 2026
30 Jun 2026 report: 120; public on 14 Aug 2026
30 Sep 2026 report: 118; public on 16 Nov 2026
Federal obligations
Month from 1 May 2022: -$1.9 published
Month from 1 Sep 2022: $18K published
Month from 1 Apr 2023: -$25K published
Month from 1 Jun 2023: $30K published
Month from 1 Aug 2023: $50K published
Month from 1 Jul 2024: $107K published
Month from 1 Jun 2025: $50K published
Month from 1 Oct 2025: $55K published
Month from 1 Mar 2026: $126K published
Month from 1 Aug 2026: $126K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $121K (18 Nov 2026), higher than 90% of its own history.
  • Insider net buying (open market): Insiders bought a net $112K in the last 12 months (the 12 months before: $373K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months, -67% on the 12 months before.
  • Revenue per quarter: Revenue $10.2M in the latest quarter, +49% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 64 insider trades

Last 90 days: no sales; 1 purchase, $121K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Nov 2026Maher MasoudPresident and CEOBuy100,000$1.21$121KForm 4
19 Mar 2026Douglas J SwirskyCHIEF FINANCIAL OFFICERSell10,142$0.82$8KForm 4
27 Aug 2025Rekha HemrajaniDirectorSellplanned in advance (10b5-1)10,684$2.09$22KForm 4
13 Aug 2025Douglas J SwirskyCHIEF FINANCIAL OFFICERBuy50,000$1.29$64KForm 4
13 Aug 2025Maher MasoudPresident and CEOBuy75,000$1.37$103KForm 4
13 Aug 2025William W BrookeDirectorBuy50,000$1.29$64KForm 4
13 Aug 2025Richard DouglasDirectorBuy80,000$1.39$111KForm 4
13 Aug 2025Stanley C ErckDirectorBuy100,000$1.37$137KForm 4

118 institutions reported shares at the end of Q3 2026, 58% of the shares outstanding; 18 opened a position, 23 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Capricorn Fund Managers Ltd8.2M7.94%$9.2MNo change
Vitruvian Partners LLP5.0M4.88%$5.6MNo change
Liontrust Investment Partners LLP4.8M4.69%$5.4MNew+4.8M
Vanguard Capital Management LLC4.0M3.88%$4.5M-22K-0.6%
Morgan Stanley4.0M3.86%$4.5M+287K+7.8%
BlackRock, Inc.3.0M2.93%$3.4M-34K-1.1%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.2.8M2.69%$3.1MNo change
Cadian Capital Management, LP2.6M2.54%$2.9M+424K+19%
Two Sigma Investments, LP2.4M2.33%$2.7M+947K+65%
Mudita Advisors LLP2.3M2.19%$2.5M-1.1M-33%

Company events

All 22 company events

In 12 months: 2 delisting notices, 1 director or officer change, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
10 Nov 2026Agreed to acquire Akron BioProducts LLC for $105.0M cash, 20,639,733 shares and $20.0M in deferred cash paymentsSame filing: sold shares privately8-K
16 Jun 2026Delisting notice or listing transfer8-K
27 Mar 2026Director or officer change8-K
20 Mar 2026Delisting notice or listing transfer8-K
22 Sep 2025Restructuring costs announced8-K
11 Aug 2025Director or officer change8-K
18 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
27 Dec 2024Director or officer change8-K

The 5 newest of 40 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

19 May 2026confirmed

Confirmed across sources Institutional holdings and Short interest and volume

MaxCyte (MXCT): had 5.4M shares sold short in the 15 Apr 2026 report, 1.6× the same report last year, while it saw 33 13F filers open a new position in the quarter ended 31 Mar 2026, 3.3× the same quarter last year. Two unrelated kinds of activity within 21 days.

  • Short interest and volume: Short interest spike, became public on 25 Apr 2026
  • Short interest and volume: Short interest spike, became public on 12 May 2026
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2026
2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M2026-04-15: 5.4M
The 15 Apr 2026 report against the 24 reports before it. this reportearliernormal: 3.5M
See the evidence (3 changes)

Short interest and volume: Short interest spike became public on 25 Apr 2026

MaxCyte had 5.4M shares sold short in the 15 Apr 2026 report, 1.6× the same report last year.

This period
5.4M (the 15 Apr 2026 report)
Normal report (median of 24 earlier)
3.5M
Typical spread (median absolute deviation)
297K
How far from its usual level
+4.3
Same report last year
3.5M
History used
1,706 days
2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M2026-04-15: 5.4M
the 15 Apr 2026 report24 earlier reportsnormal: 3.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 May 2026

MaxCyte had 5.2M shares sold short in the 30 Apr 2026 report, 1.5× the same report last year.

This period
5.2M (the 30 Apr 2026 report)
Normal report (median of 24 earlier)
3.5M
Typical spread (median absolute deviation)
323K
How far from its usual level
+3.6
Same report last year
3.5M
History used
1,721 days
2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M2026-04-15: 5.4M2026-04-30: 5.2M
the 30 Apr 2026 report24 earlier reportsnormal: 3.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 15 May 2026

MaxCyte saw 33 13F filers open a new position in the quarter ended 31 Mar 2026, 3.3× the same quarter last year.

This period
33 (the quarter ended 31 Mar 2026)
Normal quarter (median of 8 earlier)
14.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+5.0
Same quarter last year
10
History used
1,643 days
2024-03-31: 142024-06-30: 52024-09-30: 112024-12-31: 172025-03-31: 102025-06-30: 172025-09-30: 162025-12-31: 152026-03-31: 33
the quarter ended 31 Mar 20268 earlier quartersnormal: 14.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 18 Nov 2026Insiders record

    Masoud Maher (President and CEO) bought 100,000 shares of MXCT ($120,780)

  2. 16 Jun 2026Filings record

    Delisting notice or listing transfer

  3. 19 May 2026several at once

    had 5.4M shares sold short in the 15 Apr 2026 report, 1.6× the same report last year, while it saw 33 13F filers open a new position in the quarter ended 31 Mar 2026, 3.3× the same quarter last year. Two unrelated kinds of activity within 21 days.

    See the evidence (3 changes)

    Short interest and volume: Short interest spike became public on 25 Apr 2026

    MaxCyte had 5.4M shares sold short in the 15 Apr 2026 report, 1.6× the same report last year.

    This period
    5.4M (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    297K
    How far from its usual level
    +4.3
    Same report last year
    3.5M
    History used
    1,706 days
    2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M2026-04-15: 5.4M
    the 15 Apr 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 May 2026

    MaxCyte had 5.2M shares sold short in the 30 Apr 2026 report, 1.5× the same report last year.

    This period
    5.2M (the 30 Apr 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    323K
    How far from its usual level
    +3.6
    Same report last year
    3.5M
    History used
    1,721 days
    2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M2026-04-15: 5.4M2026-04-30: 5.2M
    the 30 Apr 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 15 May 2026

    MaxCyte saw 33 13F filers open a new position in the quarter ended 31 Mar 2026, 3.3× the same quarter last year.

    This period
    33 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    14.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +5.0
    Same quarter last year
    10
    History used
    1,643 days
    2024-03-31: 142024-06-30: 52024-09-30: 112024-12-31: 172025-03-31: 102025-06-30: 172025-09-30: 162025-12-31: 152026-03-31: 33
    the quarter ended 31 Mar 20268 earlier quartersnormal: 14.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  4. 15 May 2026Institutional holdings change

    saw 33 13F filers open a new position in the quarter ended 31 Mar 2026, 3.3× the same quarter last year.

    Same quarter last year: 10; its normal quarter is 14.5.

    See the evidence
    This period
    33 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    14.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +5.0
    Same quarter last year
    10
    History used
    1,643 days
    2024-03-31: 142024-06-30: 52024-09-30: 112024-12-31: 172025-03-31: 102025-06-30: 172025-09-30: 162025-12-31: 152026-03-31: 33
    the quarter ended 31 Mar 20268 earlier quartersnormal: 14.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  5. 12 May 2026Short interest and volume change

    had 5.2M shares sold short in the 30 Apr 2026 report, 1.5× the same report last year.

    Same report last year: 3.5M; its normal report is 3.5M.

    See the evidence
    This period
    5.2M (the 30 Apr 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    323K
    How far from its usual level
    +3.6
    Same report last year
    3.5M
    History used
    1,721 days
    2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M2026-04-15: 5.4M2026-04-30: 5.2M
    the 30 Apr 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 25 Apr 2026Short interest and volume change

    had 5.4M shares sold short in the 15 Apr 2026 report, 1.6× the same report last year.

    Same report last year: 3.5M; its normal report is 3.5M.

    See the evidence
    This period
    5.4M (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    297K
    How far from its usual level
    +4.3
    Same report last year
    3.5M
    History used
    1,706 days
    2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M2026-04-15: 5.4M
    the 15 Apr 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 11 Apr 2026Short interest and volume change

    had 5.6M shares sold short in the 31 Mar 2026 report, 1.7× the same report last year.

    Same report last year: 3.3M; its normal report is 3.5M.

    See the evidence
    This period
    5.6M (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    218K
    How far from its usual level
    +6.0
    Same report last year
    3.3M
    History used
    1,691 days
    2025-03-31: 3.3M2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M2026-03-31: 5.6M
    the 31 Mar 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 27 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 27 Mar 2026Filings record

    Director or officer change

  10. 25 Mar 2026Short interest and volume change

    had 5.5M shares sold short in the 13 Mar 2026 report, 1.8× the same report last year.

    Same report last year: 3.0M; its normal report is 3.5M.

    See the evidence
    This period
    5.5M (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    196K
    How far from its usual level
    +5.9
    Same report last year
    3.0M
    History used
    1,673 days
    2025-03-14: 3.0M2025-03-31: 3.3M2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M2026-03-13: 5.5M
    the 13 Mar 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 20 Mar 2026Filings record

    Delisting notice or listing transfer

  12. 11 Mar 2026Short interest and volume change

    had 5.8M shares sold short in the 27 Feb 2026 report, 2.1× the same report last year.

    Same report last year: 2.7M; its normal report is 3.4M.

    See the evidence
    This period
    5.8M (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    3.4M
    Typical spread (median absolute deviation)
    185K
    How far from its usual level
    +6.7
    Same report last year
    2.7M
    History used
    1,659 days
    2025-02-28: 2.7M2025-03-14: 3.0M2025-03-31: 3.3M2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M2026-02-27: 5.8M
    the 27 Feb 2026 report24 earlier reportsnormal: 3.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 26 Feb 2026Short interest and volume change

    had 5.1M shares sold short in the 13 Feb 2026 report, 1.8× the same report last year.

    Same report last year: 2.8M; its normal report is 3.4M.

    See the evidence
    This period
    5.1M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    3.4M
    Typical spread (median absolute deviation)
    221K
    How far from its usual level
    +5.1
    Same report last year
    2.8M
    History used
    1,645 days
    2025-02-14: 2.8M2025-02-28: 2.7M2025-03-14: 3.0M2025-03-31: 3.3M2025-04-15: 3.5M2025-04-30: 3.5M2025-05-15: 3.8M2025-05-30: 3.5M2025-06-13: 3.6M2025-06-30: 3.4M2025-07-15: 3.5M2025-07-31: 3.5M2025-08-15: 3.6M2025-08-29: 3.3M2025-09-15: 3.5M2025-09-30: 3.2M2025-10-15: 3.4M2025-10-31: 3.0M2025-11-14: 3.0M2025-11-28: 2.8M2025-12-15: 2.7M2025-12-31: 2.4M2026-01-15: 2.5M2026-01-30: 3.9M2026-02-13: 5.1M
    the 13 Feb 2026 report24 earlier reportsnormal: 3.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 22 Sep 2025Filings record

    Restructuring costs announced

  15. 14 Aug 2025Insiders change

    had 5 insiders buy $480K of its shares on the open market within 30 days (5 filings).

    Who bought: Erck Stanley C, Douglas Richard, Brooke William W, Masoud Maher and 1 more.

    See the evidence (5 source records)
    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $480K
    Window
    15 Jul 2025 to 14 Aug 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  16. 14 Aug 2025Insiders record

    Swirsky Douglas J (CHIEF FINANCIAL OFFICER) bought 50,000 shares of MXCT ($64,500) (dated 13 Aug 2025)

  17. 14 Aug 2025Insiders record

    Masoud Maher (President and CEO) bought 75,000 shares of MXCT ($102,750) (dated 13 Aug 2025)

  18. 14 Aug 2025Insiders record

    Brooke William W (director) bought 50,000 shares of MXCT ($64,500) (dated 13 Aug 2025)

  19. 14 Aug 2025Insiders record

    DOUGLAS RICHARD (director) bought 80,000 shares of MXCT ($111,200) (dated 13 Aug 2025)

  20. 14 Aug 2025Insiders record

    Erck Stanley C (director) bought 100,000 shares of MXCT ($137,000) (dated 13 Aug 2025)

  21. 11 Aug 2025Filings record

    Director or officer change

  22. 18 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 18 Jun 2025Filings record

    Director or officer change

  24. 27 Dec 2024Filings record

    Director or officer change

  25. 9 Dec 2024Filings record

    Restructuring costs announced

  26. 15 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 15 Oct 2024Filings record

    Director or officer change

  28. 12 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 12 Jun 2024Filings record

    Director or officer change

  30. 11 Jun 2024Insiders record

    Masoud Maher (President and CEO) bought 100,000 shares of MXCT ($489,113) (dated 10 Jun 2024)

  31. 26 Jan 2024Filings record

    Director or officer change

  32. 11 Jan 2024Short interest and volume change

    had 4.0M shares sold short in the 29 Dec 2023 report, 2.1× the same report last year.

    Same report last year: 1.9M; its normal report is 2.2M.

    See the evidence
    This period
    4.0M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    2.2M
    Typical spread (median absolute deviation)
    245K
    How far from its usual level
    +5.1
    Same report last year
    1.9M
    History used
    868 days
    2022-12-30: 1.9M2023-01-13: 1.9M2023-01-31: 1.8M2023-02-15: 1.8M2023-02-28: 1.7M2023-03-15: 2.1M2023-03-31: 2.4M2023-04-14: 2.3M2023-04-28: 2.4M2023-05-15: 2.3M2023-05-31: 2.3M2023-06-15: 2.2M2023-06-30: 1.9M2023-07-14: 1.9M2023-07-31: 1.9M2023-08-15: 1.9M2023-08-31: 2.0M2023-09-15: 2.1M2023-09-29: 2.3M2023-10-13: 2.5M2023-10-31: 3.3M2023-11-15: 3.0M2023-11-30: 3.1M2023-12-15: 4.0M2023-12-29: 4.0M
    the 29 Dec 2023 report24 earlier reportsnormal: 2.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 28 Dec 2023Short interest and volume change

    had 4.0M shares sold short in the 15 Dec 2023 report, 2.3× the same report last year.

    Same report last year: 1.8M; its normal report is 2.1M.

    See the evidence
    This period
    4.0M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    2.1M
    Typical spread (median absolute deviation)
    235K
    How far from its usual level
    +5.5
    Same report last year
    1.8M
    History used
    854 days
    2022-12-15: 1.8M2022-12-30: 1.9M2023-01-13: 1.9M2023-01-31: 1.8M2023-02-15: 1.8M2023-02-28: 1.7M2023-03-15: 2.1M2023-03-31: 2.4M2023-04-14: 2.3M2023-04-28: 2.4M2023-05-15: 2.3M2023-05-31: 2.3M2023-06-15: 2.2M2023-06-30: 1.9M2023-07-14: 1.9M2023-07-31: 1.9M2023-08-15: 1.9M2023-08-31: 2.0M2023-09-15: 2.1M2023-09-29: 2.3M2023-10-13: 2.5M2023-10-31: 3.3M2023-11-15: 3.0M2023-11-30: 3.1M2023-12-15: 4.0M
    the 15 Dec 2023 report24 earlier reportsnormal: 2.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 11 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 11 Dec 2023Filings record

    Director or officer change

  36. 28 Nov 2023Short interest and volume change

    had 3.0M shares sold short in the 15 Nov 2023 report, 1.5× the same report last year.

    Same report last year: 2.0M; its normal report is 2.0M.

    See the evidence
    This period
    3.0M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    173K
    How far from its usual level
    +3.9
    Same report last year
    2.0M
    History used
    824 days
    2022-11-15: 2.0M2022-11-30: 1.9M2022-12-15: 1.8M2022-12-30: 1.9M2023-01-13: 1.9M2023-01-31: 1.8M2023-02-15: 1.8M2023-02-28: 1.7M2023-03-15: 2.1M2023-03-31: 2.4M2023-04-14: 2.3M2023-04-28: 2.4M2023-05-15: 2.3M2023-05-31: 2.3M2023-06-15: 2.2M2023-06-30: 1.9M2023-07-14: 1.9M2023-07-31: 1.9M2023-08-15: 1.9M2023-08-31: 2.0M2023-09-15: 2.1M2023-09-29: 2.3M2023-10-13: 2.5M2023-10-31: 3.3M2023-11-15: 3.0M
    the 15 Nov 2023 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 10 Nov 2023Short interest and volume change

    had 3.3M shares sold short in the 31 Oct 2023 report, 1.2× the same report last year.

    Same report last year: 2.7M; its normal report is 2.0M.

    See the evidence
    This period
    3.3M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    173K
    How far from its usual level
    +5.0
    Same report last year
    2.7M
    History used
    809 days
    2022-10-31: 2.7M2022-11-15: 2.0M2022-11-30: 1.9M2022-12-15: 1.8M2022-12-30: 1.9M2023-01-13: 1.9M2023-01-31: 1.8M2023-02-15: 1.8M2023-02-28: 1.7M2023-03-15: 2.1M2023-03-31: 2.4M2023-04-14: 2.3M2023-04-28: 2.4M2023-05-15: 2.3M2023-05-31: 2.3M2023-06-15: 2.2M2023-06-30: 1.9M2023-07-14: 1.9M2023-07-31: 1.9M2023-08-15: 1.9M2023-08-31: 2.0M2023-09-15: 2.1M2023-09-29: 2.3M2023-10-13: 2.5M2023-10-31: 3.3M
    the 31 Oct 2023 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 23 Jun 2023Filings record

    Director or officer change

  39. 31 Mar 2023Insiders record

    DOUGLAS RICHARD (director) bought 80,000 shares of MXCT ($345,600) (dated 30 Mar 2023)

  40. 28 Mar 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 55 entries; narrow the window or the kind of data to see older ones.

Not listed: 110 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001287098
Ticker
MXCT
Domain
maxcyte.com
Employer name
MaxCyte, Inc. (1 unverified)
Hq location
MD|ROCKVILLE|20850 (1 unverified)
Name
CCTI, Inc, MaxCyte, Inc., SeQure DX Inc
Uei
KM8DZV21HFM8
Wikidata
Q30290314
  • DOL H-1B labor condition applications and PERM certifications52 data points13 Apr 2020 to 25 May 2026
  • SEC Form 13F institutional holdings189 data points30 Sep 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)77 records29 Sep 2016 to 10 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)529 data points31 Dec 2018 to 6 Nov 2026
  • SEC Form 4 insider transactions64 records, 196 data points3 Aug 2021 to 18 Nov 2026
  • FINRA short interest (twice monthly)374 data points13 Aug 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2670 data points30 Jul 2021 to 20 Nov 2026
  • USASpending.gov federal awards105 data points14 Mar 2008 to 20 Aug 2026